§ PHARMACEUTICALS
USD · Pharmaceuticals

CGC

CANOPY GROWTH CORP
USDSector · PharmaceuticalsBeta · 2.07
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
84 increased/new, 38 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B0.57EPS (TTM)-1.84
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Tidal Investments LLC8.5M0.0%+26%
Morgan Stanley2.0M0.0%−48%
LAZARD ASSET MANAGEMENT LLC1.8M0.0%n/a
JANE STREET GROUP, LLC1.6M0.0%−79%
Goldman Sachs1.3M0.0%+62%
Citadel Advisors1.1M0.0%−44%
◇ AC INTELLIGENCE

Top institutional owners for CGC as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER94.0% · 0 holders
OTHER3.7% · 187 holders
DEALER / BANK1.0% · 24 holders
TACTICAL / MACRO0.6% · 2 holders
SYSTEMATIC / QUANT0.5% · 5 holders
ACTIVIST0.1% · 1 holder
QUALITY / COMPOUNDER0.1% · 3 holders
PASSIVE / INDEX0.0% · 2 holders
INCOME / DEFENSIVE0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for CGC in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention CGC yet.